Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
Open Access
- 11 November 2008
- journal article
- Published by Springer Nature in Journal of Autoimmune Diseases
- Vol. 5 (1) , 6
- https://doi.org/10.1186/1740-2557-5-6
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 monthsJournal of Thrombosis and Haemostasis, 2006
- Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic AttackStroke, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Thrombotic Risk Factors In Primary Antiphospholipid SyndromeStroke, 2005
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patientsArthritis & Rheumatism, 2005
- Thrombosis and the Antiphospholipid SyndromeHematology-American Society Hematology Education Program, 2005
- Deep Venous ThrombosisHematology-American Society Hematology Education Program, 2004
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia.Stroke, 1992